Trial intelligence / Profile preview

L. reuteri Prodentis for Mucositis and Periimplantitis

NCT03047291Phase 4Completed

Sponsor
Universitat Internacional de Catalunya
Start
Jan 2014
Primary completion
Mar 2017
Modality
Live Biotherapeutic Products
01

Overview

A Phase 4 trial of L. reuteri Prodentis in peri-implant mucositis, peri-implantitis, sponsored by Universitat Internacional de Catalunya. Started Jan 2014; status: completed.

02

Drugs

L. reuteri Prodentis
03

Conditions

peri-implant mucositisperi-implantitis

Beyond the preview

Go deeper on NCT03047291.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03047291.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call